<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/C0805014-A6FD-41C1-81BE-B94AE4139F25"><gtr:id>C0805014-A6FD-41C1-81BE-B94AE4139F25</gtr:id><gtr:name>Max Planck Society</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/89F66D08-390A-4D3A-9C7C-6780F6F7A1AC"><gtr:id>89F66D08-390A-4D3A-9C7C-6780F6F7A1AC</gtr:id><gtr:name>University of Southern Denmark</gtr:name><gtr:address><gtr:line1>Campusvej 55</gtr:line1><gtr:line4>Odense M</gtr:line4><gtr:postCode>DK-5230</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Denmark</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/1354C618-9C7F-4E90-97AE-2A04B4C8536D"><gtr:id>1354C618-9C7F-4E90-97AE-2A04B4C8536D</gtr:id><gtr:name>Cancer Research UK (CRUK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/C0805014-A6FD-41C1-81BE-B94AE4139F25"><gtr:id>C0805014-A6FD-41C1-81BE-B94AE4139F25</gtr:id><gtr:name>Max Planck Society</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/89F66D08-390A-4D3A-9C7C-6780F6F7A1AC"><gtr:id>89F66D08-390A-4D3A-9C7C-6780F6F7A1AC</gtr:id><gtr:name>University of Southern Denmark</gtr:name><gtr:address><gtr:line1>Campusvej 55</gtr:line1><gtr:line4>Odense M</gtr:line4><gtr:postCode>DK-5230</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Denmark</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/1354C618-9C7F-4E90-97AE-2A04B4C8536D"><gtr:id>1354C618-9C7F-4E90-97AE-2A04B4C8536D</gtr:id><gtr:name>Cancer Research UK (CRUK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/70DCA67A-7848-495D-8C3B-5BE43B80C47D"><gtr:id>70DCA67A-7848-495D-8C3B-5BE43B80C47D</gtr:id><gtr:firstName>Angus</gtr:firstName><gtr:otherNames>Iain</gtr:otherNames><gtr:surname>Lamond</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0301131"><gtr:id>9CF3EC21-D8D3-41A4-9932-1EAFC7ECEFDC</gtr:id><gtr:title>Proteomic Analysis of the Function of Nuclear SUMO Modification</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0301131</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2007-09-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2004-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>424207</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cancer Research UK (CRUK)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>The Beatson Institute for Cancer Research</gtr:department><gtr:description>RASOR</gtr:description><gtr:id>24C7F9FE-41F9-49B9-A5B9-BD6146B53A0A</gtr:id><gtr:impact>Publications: PubMed ID 18936248 PubMed ID 19935650</gtr:impact><gtr:partnerContribution>N/A</gtr:partnerContribution><gtr:piContribution>Joint project with Edinbugh and Glasgow Universities.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Max Planck Society</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Max Planck Institute of Biochemistry</gtr:department><gtr:description>co-author Matthias Mann</gtr:description><gtr:id>A01BC254-0A9E-4BDC-A35E-A5371978A74E</gtr:id><gtr:impact>PMID: 16381850 
PMID: 16492807
PMID: 17000644 
PMID: 17446074 
PMID: 17938407 
PMID: 22311636</gtr:impact><gtr:partnerContribution>co-author</gtr:partnerContribution><gtr:piContribution>Publication</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Dundee</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Wellcome Trust Centre for Gene Regulation and Expression</gtr:department><gtr:description>co-author Ron Hay</gtr:description><gtr:id>6CCB416A-8D9F-4869-B5A6-EACE1D039627</gtr:id><gtr:impact>Publications - 15175327 / 17000644 / 17938407 (Pubmed)</gtr:impact><gtr:partnerContribution>co-authors</gtr:partnerContribution><gtr:piContribution>Publications</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Southern Denmark (Syddansk Universitet)</gtr:collaboratingOrganisation><gtr:country>Denmark, Kingdom of</gtr:country><gtr:description>co-author Jens Andersen</gtr:description><gtr:id>61CBD406-EA38-40C8-A8E0-453F1753FAB4</gtr:id><gtr:impact>PMID: 16381850 
PMID: 17000644 
PMID: 17446074 
PMID: 22311636</gtr:impact><gtr:partnerContribution>co-author</gtr:partnerContribution><gtr:piContribution>Publication</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School Visit - Fife</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>D7F20CB7-FA28-4480-8C83-6C64EAAE7ADF</gtr:id><gtr:impact>Presentation of research to school children

Positive feedback from schools and being invited back</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Seminar Speaker</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>349DF76E-1153-4F2B-9D68-A44F1A19086A</gtr:id><gtr:impact>Presentations of results

Regularly invited as a seminar speaker</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>Dundee Cell Products</gtr:companyName><gtr:description>Dundee Cell Products (DCP) is a spin out company of University of Dundee of which Angus I Lamond is a co-founder. http://www.dundeecellproducts.com/ ; http://www.dundeecellproducts.com</gtr:description><gtr:id>669DAD77-A778-4BD6-BE43-8A91F7B8EF6A</gtr:id><gtr:impact>1. Dundee Cell Products has successfully commercialised SILAC quantitative proteomics technology to academic and commercial customers. It has carried out SILAC analysis for customers in about six universities and recently gained a service contract with one of the world's largest pharmaceutical companies to apply this technology in their drug discovery and development process. The company has also developed various SILAC ready-to-use tissue culture media that facilitate the culture of cell lines for subsequent quantitative proteomics analysis. These special SILAC media have gained customers all over Europe and in North America. 
2. Since spinout, the company has commercialised life sciences research reagents including antibodies, recombinant proteins, DNA clones, stable cell lines, etc., many of which have been developed or licensed from Universities/academic institutions. 
3. The company has created new jobs by employing five highly skilled staff (3 post-doctoral, two undergraduates). It also provides part-time work to two contractors (bookkeeper and accountant), work to local businesses and outsources some work to the University of Dundee thus providing extra revenue to the institution.</gtr:impact><gtr:url>http://www.dundeecellproducts.com/</gtr:url><gtr:yearCompanyFormed>2006</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1FE600D1-EAD8-4E33-B6F7-851D3ADF1866"><gtr:id>1FE600D1-EAD8-4E33-B6F7-851D3ADF1866</gtr:id><gtr:title>The serine/arginine-rich protein SF2/ASF regulates protein sumoylation.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b090385ee7429aceaa8cf36066c43037"><gtr:id>b090385ee7429aceaa8cf36066c43037</gtr:id><gtr:otherNames>Pelisch F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/186B903B-8279-465B-8359-964E0B2D318F"><gtr:id>186B903B-8279-465B-8359-964E0B2D318F</gtr:id><gtr:title>A role for SUMOylation in snoRNP biogenesis revealed by quantitative proteomics.</gtr:title><gtr:parentPublicationTitle>Nucleus (Austin, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7405dbde812062bcbd4a27ff9552dfb6"><gtr:id>7405dbde812062bcbd4a27ff9552dfb6</gtr:id><gtr:otherNames>Westman BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1949-1034</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A5A0EFA3-A3C1-49E6-8A78-D8A2DFB64981"><gtr:id>A5A0EFA3-A3C1-49E6-8A78-D8A2DFB64981</gtr:id><gtr:title>A proteomic screen for nucleolar SUMO targets shows SUMOylation modulates the function of Nop5/Nop58.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7405dbde812062bcbd4a27ff9552dfb6"><gtr:id>7405dbde812062bcbd4a27ff9552dfb6</gtr:id><gtr:otherNames>Westman BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1F559E1A-5C82-4AE2-BADD-774B4FEE01B6"><gtr:id>1F559E1A-5C82-4AE2-BADD-774B4FEE01B6</gtr:id><gtr:title>A proteomic study of SUMO-2 target proteins.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/38ffed33892234447695f3c26d7215d5"><gtr:id>38ffed33892234447695f3c26d7215d5</gtr:id><gtr:otherNames>Vertegaal AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AEF06AB8-868F-4179-B434-E6F8EADB7723"><gtr:id>AEF06AB8-868F-4179-B434-E6F8EADB7723</gtr:id><gtr:title>Distinct and overlapping sets of SUMO-1 and SUMO-2 target proteins revealed by quantitative proteomics.</gtr:title><gtr:parentPublicationTitle>Molecular &amp; cellular proteomics : MCP</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/38ffed33892234447695f3c26d7215d5"><gtr:id>38ffed33892234447695f3c26d7215d5</gtr:id><gtr:otherNames>Vertegaal AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1535-9476</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F5702B11-71FC-467E-8782-BDA5F305BD26"><gtr:id>F5702B11-71FC-467E-8782-BDA5F305BD26</gtr:id><gtr:title>In vivo identification of human small ubiquitin-like modifier polymerization sites by high accuracy mass spectrometry and an in vitro to in vivo strategy.</gtr:title><gtr:parentPublicationTitle>Molecular &amp; cellular proteomics : MCP</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0c967aeac745ed9d23adaeac49e92894"><gtr:id>0c967aeac745ed9d23adaeac49e92894</gtr:id><gtr:otherNames>Matic I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1535-9476</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0301131</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>